Medtech Spinouts: Bench to Bedside
Join us for Nucleate Dojo's second event of the semester! Our panel will dive into the exciting journey of turning academic breakthroughs into thriving medtech startups. If you're curious about where academia and industry intersect or eager to learn how to overcome the unique challenges of this space — come connect with us! This event is an inspiring chance to explore how innovation can bridge biotech with real-world impact.
Our speakers:
Margaret Magdesian completed her bachelor’s of science in pharmacology and her PhD in Biochemistry from the University of São Paulo in 2001. She then collaborated with researchers from McGill University to develop nervous-system-lab-on-a-chip technologies. In 2015, Dr. Magdesian founded Ananda Devices Inc. to accelerate drug discovery leveraging her developed technology to offer proprietary high throughput cellular and tissue nano-organization services to accelerate R&D in pharmaceutical, food and cosmetic (PFC) industries. This earned her the Quebec Discovery of the Year Award in 2016.
Edward Harvey is a professor of surgery at McGill University and his research focuses on the repair and recovery of orthopedic trauma patients and is the leader of the trauma research program at the Research Institute of the McGill University Health Center (RI-MUHC). Along with Charles Allan and George Xereas, Dr. Harvey co-founded MY01 in 2019. MY01 offers a medical device that provides reliable, and real-time continuous pressure measurements to aid in the diagnosis of compartment syndrome. He is now the Chairman of the Board and Chief Medical officer at MY01.
Hugo Level completed his bachelor’s of engineering in biotechnology at ESCPCI Paris in 2020 and then went on to pursue his PhD at McGill in chemical engineering under Prof. Corinne Hoesli’s supervision. During this time, he co-cofounded Capcyte Biotherapeutics alongside Marc-Antoine Campeau in 2022. They are developing an implant functionalization technology that enables surface modification to enhance their biocompatibility and regenerative potential.
Amy Lorincz is the Co-Founder and CEO of Vope Medical, where she drives the development of an AI-powered software to enhance vision in minimally invasive surgery. With a background in industrial engineering and a master’s in experimental surgery, she brings extensive experience in MedTech, including developing surgical robots, conducting clinical validations research, and raising capital. Amy is passionate about making advancements in the healthcare field, with a vision to empower surgical teams with cutting-edge, vision enhancing tools for safer and more efficient surgeries.
We can’t wait to see you there!